Intel unveiled the Core Processor Series 2, specialized for industrial edge applications, ahead of the Embedded World 2026 event, which runs for three days from the 10th to the 12th in Nuremberg, Germany.
Since the 12th-generation Core processor (Alder Lake), Intel has applied a hybrid architecture that combines high-performance P (performance) cores and low-power, high-efficiency E (efficient) cores.
In contrast, the Core Processor Series 2 maximizes compute performance and reduces latency by equipping up to 12 P-cores only. It is built on Intel 7, and the P-core type is Raptor Cove, the same as the 13th and 14th generation Core processors.
The supported socket is LGA 1700, compatible with existing platforms. A total of 11 processors, including the Core 9 273PE with 12 cores running at 5.7 GHz, will be supplied to major system manufacturers.
Edge systems based on Intel Core Processor Series 2 and edge systems based on Core Ultra Series 3 are currently being sold through major embedded manufacturers.
Intel also unveiled the Edge AI Suite for Healthcare and Life Sciences, a framework for building patient monitoring solutions that run locally, such as arrhythmia detection using AI-based electrocardiograms and laser speckle contrast imaging.
OEMs, ODMs, and ISVs can use this suite to evaluate the platform based on representative scenarios that reflect real-world environments. A preview version is available on GitHub, with an official release planned in the second quarter of this year.